Global Human Rotavirus Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
The Human Rotavirus Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Human Rotavirus Vaccine market size is estimated to be worth US$ 6949.3 million in 2021 and is forecast to a readjusted size of USD 10430 million by 2028 with a CAGR of 6.0% during review period. Hospitals & Clinics accounting for % of the Human Rotavirus Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Rotarix segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Human Rotavirus Vaccine include Bharat Biotech, Merck, GlaxoSmithKline, , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Human Rotavirus Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou lamb
Others
Market segment by Application can be divided into
Hospitals & Clinics
Academic And Research
Others
The key market players for global Human Rotavirus Vaccine market are listed below:
Bharat Biotech
Merck
GlaxoSmithKline
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Rotavirus Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Rotavirus Vaccine, with price, sales, revenue and global market share of Human Rotavirus Vaccine from 2019 to 2022.
Chapter 3, the Human Rotavirus Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Rotavirus Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Human Rotavirus Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Human Rotavirus Vaccine.
Chapter 13, 14, and 15, to describe Human Rotavirus Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Human Rotavirus Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Rotavirus Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Rotarix
1.2.3 RotaTeq
1.2.4 Rotavac
1.2.5 Rotavin-M1
1.2.6 Lanzhou lamb
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Rotavirus Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals & Clinics
1.3.3 Academic And Research
1.3.4 Others
1.4 Global Human Rotavirus Vaccine Market Size & Forecast
1.4.1 Global Human Rotavirus Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Human Rotavirus Vaccine Sales in Volume (2017-2028)
1.4.3 Global Human Rotavirus Vaccine Price (2017-2028)
1.5 Global Human Rotavirus Vaccine Production Capacity Analysis
1.5.1 Global Human Rotavirus Vaccine Total Production Capacity (2017-2028)
1.5.2 Global Human Rotavirus Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Human Rotavirus Vaccine Market Drivers
1.6.2 Human Rotavirus Vaccine Market Restraints
1.6.3 Human Rotavirus Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Bharat Biotech
2.1.1 Bharat Biotech Details
2.1.2 Bharat Biotech Major Business
2.1.3 Bharat Biotech Human Rotavirus Vaccine Product and Services
2.1.4 Bharat Biotech Human Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Human Rotavirus Vaccine Product and Services
2.2.4 Merck Human Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline Human Rotavirus Vaccine Product and Services
2.3.4 GlaxoSmithKline Human Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Human Rotavirus Vaccine Breakdown Data by Manufacturer
3.1 Global Human Rotavirus Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Human Rotavirus Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Human Rotavirus Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Human Rotavirus Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Human Rotavirus Vaccine Manufacturer Market Share in 2021
3.5 Global Human Rotavirus Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Human Rotavirus Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Human Rotavirus Vaccine Market Size by Region
4.1.1 Global Human Rotavirus Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global Human Rotavirus Vaccine Revenue by Region (2017-2028)
4.2 North America Human Rotavirus Vaccine Revenue (2017-2028)
4.3 Europe Human Rotavirus Vaccine Revenue (2017-2028)
4.4 Asia-Pacific Human Rotavirus Vaccine Revenue (2017-2028)
4.5 South America Human Rotavirus Vaccine Revenue (2017-2028)
4.6 Middle East and Africa Human Rotavirus Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Human Rotavirus Vaccine Sales in Volume by Type (2017-2028)
5.2 Global Human Rotavirus Vaccine Revenue by Type (2017-2028)
5.3 Global Human Rotavirus Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Human Rotavirus Vaccine Sales in Volume by Application (2017-2028)
6.2 Global Human Rotavirus Vaccine Revenue by Application (2017-2028)
6.3 Global Human Rotavirus Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Human Rotavirus Vaccine Sales by Type (2017-2028)
7.2 North America Human Rotavirus Vaccine Sales by Application (2017-2028)
7.3 North America Human Rotavirus Vaccine Market Size by Country
7.3.1 North America Human Rotavirus Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America Human Rotavirus Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Human Rotavirus Vaccine Sales by Type (2017-2028)
8.2 Europe Human Rotavirus Vaccine Sales by Application (2017-2028)
8.3 Europe Human Rotavirus Vaccine Market Size by Country
8.3.1 Europe Human Rotavirus Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe Human Rotavirus Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Human Rotavirus Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific Human Rotavirus Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific Human Rotavirus Vaccine Market Size by Region
9.3.1 Asia-Pacific Human Rotavirus Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Human Rotavirus Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Human Rotavirus Vaccine Sales by Type (2017-2028)
10.2 South America Human Rotavirus Vaccine Sales by Application (2017-2028)
10.3 South America Human Rotavirus Vaccine Market Size by Country
10.3.1 South America Human Rotavirus Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America Human Rotavirus Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Human Rotavirus Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa Human Rotavirus Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa Human Rotavirus Vaccine Market Size by Country
11.3.1 Middle East & Africa Human Rotavirus Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Human Rotavirus Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Human Rotavirus Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Human Rotavirus Vaccine
12.3 Human Rotavirus Vaccine Production Process
12.4 Human Rotavirus Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Human Rotavirus Vaccine Typical Distributors
13.3 Human Rotavirus Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Human Rotavirus Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Human Rotavirus Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 4. Bharat Biotech Major Business
Table 5. Bharat Biotech Human Rotavirus Vaccine Product and Services
Table 6. Bharat Biotech Human Rotavirus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck Major Business
Table 9. Merck Human Rotavirus Vaccine Product and Services
Table 10. Merck Human Rotavirus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 12. GlaxoSmithKline Major Business
Table 13. GlaxoSmithKline Human Rotavirus Vaccine Product and Services
Table 14. GlaxoSmithKline Human Rotavirus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Global Human Rotavirus Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 16. Global Human Rotavirus Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 17. Market Position of Manufacturers in Human Rotavirus Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 18. Global Human Rotavirus Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
Table 19. Head Office and Human Rotavirus Vaccine Production Site of Key Manufacturer
Table 20. Human Rotavirus Vaccine New Entrant and Capacity Expansion Plans
Table 21. Human Rotavirus Vaccine Mergers & Acquisitions in the Past Five Years
Table 22. Global Human Rotavirus Vaccine Sales by Region (2017-2022) & (K Units)
Table 23. Global Human Rotavirus Vaccine Sales by Region (2023-2028) & (K Units)
Table 24. Global Human Rotavirus Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 25. Global Human Rotavirus Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 26. Global Human Rotavirus Vaccine Sales by Type (2017-2022) & (K Units)
Table 27. Global Human Rotavirus Vaccine Sales by Type (2023-2028) & (K Units)
Table 28. Global Human Rotavirus Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 29. Global Human Rotavirus Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 30. Global Human Rotavirus Vaccine Price by Type (2017-2022) & (USD/Unit)
Table 31. Global Human Rotavirus Vaccine Price by Type (2023-2028) & (USD/Unit)
Table 32. Global Human Rotavirus Vaccine Sales by Application (2017-2022) & (K Units)
Table 33. Global Human Rotavirus Vaccine Sales by Application (2023-2028) & (K Units)
Table 34. Global Human Rotavirus Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 35. Global Human Rotavirus Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 36. Global Human Rotavirus Vaccine Price by Application (2017-2022) & (USD/Unit)
Table 37. Global Human Rotavirus Vaccine Price by Application (2023-2028) & (USD/Unit)
Table 38. North America Human Rotavirus Vaccine Sales by Country (2017-2022) & (K Units)
Table 39. North America Human Rotavirus Vaccine Sales by Country (2023-2028) & (K Units)
Table 40. North America Human Rotavirus Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 41. North America Human Rotavirus Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 42. North America Human Rotavirus Vaccine Sales by Type (2017-2022) & (K Units)
Table 43. North America Human Rotavirus Vaccine Sales by Type (2023-2028) & (K Units)
Table 44. North America Human Rotavirus Vaccine Sales by Application (2017-2022) & (K Units)
Table 45. North America Human Rotavirus Vaccine Sales by Application (2023-2028) & (K Units)
Table 46. Europe Human Rotavirus Vaccine Sales by Country (2017-2022) & (K Units)
Table 47. Europe Human Rotavirus Vaccine Sales by Country (2023-2028) & (K Units)
Table 48. Europe Human Rotavirus Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 49. Europe Human Rotavirus Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 50. Europe Human Rotavirus Vaccine Sales by Type (2017-2022) & (K Units)
Table 51. Europe Human Rotavirus Vaccine Sales by Type (2023-2028) & (K Units)
Table 52. Europe Human Rotavirus Vaccine Sales by Application (2017-2022) & (K Units)
Table 53. Europe Human Rotavirus Vaccine Sales by Application (2023-2028) & (K Units)
Table 54. Asia-Pacific Human Rotavirus Vaccine Sales by Region (2017-2022) & (K Units)
Table 55. Asia-Pacific Human Rotavirus Vaccine Sales by Region (2023-2028) & (K Units)
Table 56. Asia-Pacific Human Rotavirus Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 57. Asia-Pacific Human Rotavirus Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 58. Asia-Pacific Human Rotavirus Vaccine Sales by Type (2017-2022) & (K Units)
Table 59. Asia-Pacific Human Rotavirus Vaccine Sales by Type (2023-2028) & (K Units)
Table 60. Asia-Pacific Human Rotavirus Vaccine Sales by Application (2017-2022) & (K Units)
Table 61. Asia-Pacific Human Rotavirus Vaccine Sales by Application (2023-2028) & (K Units)
Table 62. South America Human Rotavirus Vaccine Sales by Country (2017-2022) & (K Units)
Table 63. South America Human Rotavirus Vaccine Sales by Country (2023-2028) & (K Units)
Table 64. South America Human Rotavirus Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 65. South America Human Rotavirus Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 66. South America Human Rotavirus Vaccine Sales by Type (2017-2022) & (K Units)
Table 67. South America Human Rotavirus Vaccine Sales by Type (2023-2028) & (K Units)
Table 68. South America Human Rotavirus Vaccine Sales by Application (2017-2022) & (K Units)
Table 69. South America Human Rotavirus Vaccine Sales by Application (2023-2028) & (K Units)
Table 70. Middle East & Africa Human Rotavirus Vaccine Sales by Region (2017-2022) & (K Units)
Table 71. Middle East & Africa Human Rotavirus Vaccine Sales by Region (2023-2028) & (K Units)
Table 72. Middle East & Africa Human Rotavirus Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 73. Middle East & Africa Human Rotavirus Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 74. Middle East & Africa Human Rotavirus Vaccine Sales by Type (2017-2022) & (K Units)
Table 75. Middle East & Africa Human Rotavirus Vaccine Sales by Type (2023-2028) & (K Units)
Table 76. Middle East & Africa Human Rotavirus Vaccine Sales by Application (2017-2022) & (K Units)
Table 77. Middle East & Africa Human Rotavirus Vaccine Sales by Application (2023-2028) & (K Units)
Table 78. Human Rotavirus Vaccine Raw Material
Table 79. Key Manufacturers of Human Rotavirus Vaccine Raw Materials
Table 80. Direct Channel Pros & Cons
Table 81. Indirect Channel Pros & Cons
Table 82. Human Rotavirus Vaccine Typical Distributors
Table 83. Human Rotavirus Vaccine Typical Customers
List of Figures
Figure 1. Human Rotavirus Vaccine Picture
Figure 2. Global Human Rotavirus Vaccine Revenue Market Share by Type in 2021
Figure 3. Rotarix
Figure 4. RotaTeq
Figure 5. Rotavac
Figure 6. Rotavin-M1
Figure 7. Lanzhou lamb
Figure 8. Others
Figure 9. Global Human Rotavirus Vaccine Revenue Market Share by Application in 2021
Figure 10. Hospitals & Clinics
Figure 11. Academic And Research
Figure 12. Others
Figure 13. Global Human Rotavirus Vaccine Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 14. Global Human Rotavirus Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Human Rotavirus Vaccine Sales (2017-2028) & (K Units)
Figure 16. Global Human Rotavirus Vaccine Price (2017-2028) & (USD/Unit)
Figure 17. Global Human Rotavirus Vaccine Production Capacity (2017-2028) & (K Units)
Figure 18. Global Human Rotavirus Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 19. Human Rotavirus Vaccine Market Drivers
Figure 20. Human Rotavirus Vaccine Market Restraints
Figure 21. Human Rotavirus Vaccine Market Trends
Figure 22. Global Human Rotavirus Vaccine Sales Market Share by Manufacturer in 2021
Figure 23. Global Human Rotavirus Vaccine Revenue Market Share by Manufacturer in 2021
Figure 24. Human Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 25. Top 3 Human Rotavirus Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 26. Top 6 Human Rotavirus Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 27. Global Human Rotavirus Vaccine Sales Market Share by Region (2017-2028)
Figure 28. Global Human Rotavirus Vaccine Revenue Market Share by Region (2017-2028)
Figure 29. North America Human Rotavirus Vaccine Revenue (2017-2028) & (USD Million)
Figure 30. Europe Human Rotavirus Vaccine Revenue (2017-2028) & (USD Million)
Figure 31. Asia-Pacific Human Rotavirus Vaccine Revenue (2017-2028) & (USD Million)
Figure 32. South America Human Rotavirus Vaccine Revenue (2017-2028) & (USD Million)
Figure 33. Middle East & Africa Human Rotavirus Vaccine Revenue (2017-2028) & (USD Million)
Figure 34. Global Human Rotavirus Vaccine Sales Market Share by Type (2017-2028)
Figure 35. Global Human Rotavirus Vaccine Revenue Market Share by Type (2017-2028)
Figure 36. Global Human Rotavirus Vaccine Price by Type (2017-2028) & (USD/Unit)
Figure 37. Global Human Rotavirus Vaccine Sales Market Share by Application (2017-2028)
Figure 38. Global Human Rotavirus Vaccine Revenue Market Share by Application (2017-2028)
Figure 39. Global Human Rotavirus Vaccine Price by Application (2017-2028) & (USD/Unit)
Figure 40. North America Human Rotavirus Vaccine Sales Market Share by Type (2017-2028)
Figure 41. North America Human Rotavirus Vaccine Sales Market Share by Application (2017-2028)
Figure 42. North America Human Rotavirus Vaccine Sales Market Share by Country (2017-2028)
Figure 43. North America Human Rotavirus Vaccine Revenue Market Share by Country (2017-2028)
Figure 44. United States Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Human Rotavirus Vaccine Sales Market Share by Type (2017-2028)
Figure 48. Europe Human Rotavirus Vaccine Sales Market Share by Application (2017-2028)
Figure 49. Europe Human Rotavirus Vaccine Sales Market Share by Country (2017-2028)
Figure 50. Europe Human Rotavirus Vaccine Revenue Market Share by Country (2017-2028)
Figure 51. Germany Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Human Rotavirus Vaccine Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Human Rotavirus Vaccine Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Human Rotavirus Vaccine Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Human Rotavirus Vaccine Revenue Market Share by Region (2017-2028)
Figure 60. China Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Korea Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Human Rotavirus Vaccine Sales Market Share by Type (2017-2028)
Figure 67. South America Human Rotavirus Vaccine Sales Market Share by Application (2017-2028)
Figure 68. South America Human Rotavirus Vaccine Sales Market Share by Country (2017-2028)
Figure 69. South America Human Rotavirus Vaccine Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East & Africa Human Rotavirus Vaccine Sales Market Share by Type (2017-2028)
Figure 73. Middle East & Africa Human Rotavirus Vaccine Sales Market Share by Application (2017-2028)
Figure 74. Middle East & Africa Human Rotavirus Vaccine Sales Market Share by Region (2017-2028)
Figure 75. Middle East & Africa Human Rotavirus Vaccine Revenue Market Share by Region (2017-2028)
Figure 76. Turkey Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Egypt Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. South Africa Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Manufacturing Cost Structure Analysis of Human Rotavirus Vaccine in 2021
Figure 81. Manufacturing Process Analysis of Human Rotavirus Vaccine
Figure 82. Human Rotavirus Vaccine Industrial Chain
Figure 83. Sales Channel: Direct Channel vs Indirect Channel
Figure 84. Methodology
Figure 85. Research Process and Data Source
